StudyFinds' Dr. Faith Coleman explains what happens when patients stop taking popular weight loss medications.

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...

Who knew weight loss and wine could be frenemies? My journey with Ozempic started as a bid to shed pounds, but it ...

New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

There has been a lot of conversation lately about if new weight loss drugs like Wegovy and Mounjaro should be covered by ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

However, the drugs have their limits -- such as weight-loss plateaus and weight regain after stopping treatment -- and as ...

Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD).

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.